Research Summary
Next Generation Antibody Therapeutics refer to a class of advanced therapeutic molecules that utilize innovative design and engineering strategies to enhance the efficacy, specificity, and functionality of antibody-based therapies. These therapeutics are developed by modifying the structure and properties of traditional monoclonal antibodies (mAbs) to improve their therapeutic potential. Next Generation Antibody Therapeutics may include antibody-drug conjugates (ADCs), bispecific antibodies, antibody fragments, Fc-engineered antibodies, and other antibody-based formats. These advancements enable precise targeting of specific disease targets, enhanced binding affinity, prolonged half-life, reduced immunogenicity, and improved tissue penetration. Next Generation Antibody Therapeutics offer promising opportunities for the treatment of various diseases, including cancer, autoimmune disorders, infectious diseases, and neurological conditions, with the potential to provide more effective and personalized therapeutic options for patients.
According to DIResearch's in-depth investigation and research, the global Next Generation Antibody Therapeutics market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of Next Generation Antibody Therapeutics include Roche, Amgen, Pfizer, Takeda, Daiichi Sankyo, Seagen, Astellas, GSK, Immunomedics, Immunocore, ADC Therapeutics etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of Next Generation Antibody Therapeutics. Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Next Generation Antibody Therapeutics market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Next Generation Antibody Therapeutics market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Next Generation Antibody Therapeutics industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Next Generation Antibody Therapeutics Include:
Roche
Amgen
Pfizer
Takeda
Daiichi Sankyo
Seagen
Astellas
GSK
Immunomedics
Immunocore
ADC Therapeutics
Next Generation Antibody Therapeutics Product Segment Include:
Antibody Drug Conjugate (ADC)
Bispecific Antibody (BsAb)
Next Generation Antibody Therapeutics Product Application Include:
Cancer
Haemophilia
Other
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global Next Generation Antibody Therapeutics Industry PESTEL Analysis
Chapter 3: Global Next Generation Antibody Therapeutics Industry Porter's Five Forces Analysis
Chapter 4: Global Next Generation Antibody Therapeutics Major Regional Market Size and Forecast Analysis
Chapter 5: Global Next Generation Antibody Therapeutics Market Size and Forecast by Type and Application Analysis
Chapter 6: North America Next Generation Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe Next Generation Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China Next Generation Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) Next Generation Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America Next Generation Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa Next Generation Antibody Therapeutics Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global Next Generation Antibody Therapeutics Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 Next Generation Antibody Therapeutics Market Overview 1.1 Product Definition and Statistical Scope 1.2 Next Generation Antibody Therapeutics Product by Type 1.2.1 Global Next Generation Antibody Therapeutics Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 Antibody Drug Conjugate (ADC) 1.2.3 Bispecific Antibody (BsAb) 1.3 Next Generation Antibody Therapeutics Product by Application 1.3.1 Global Next Generation Antibody Therapeutics Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Cancer 1.3.3 Haemophilia 1.3.4 Other 1.4 Global Next Generation Antibody Therapeutics Market Revenue Analysis (2019-2030) 1.5 Next Generation Antibody Therapeutics Market Development Status and Trends 1.5.1 Next Generation Antibody Therapeutics Industry Development Status Analysis 1.5.2 Next Generation Antibody Therapeutics Industry Development Trends Analysis 2 Next Generation Antibody Therapeutics Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 Next Generation Antibody Therapeutics Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global Next Generation Antibody Therapeutics Market Analysis by Regions 4.1 Next Generation Antibody Therapeutics Overall Market: 2023 VS 2024 VS 2030 4.2 Global Next Generation Antibody Therapeutics Revenue and Forecast Analysis (2019-2030) 4.2.1 Global Next Generation Antibody Therapeutics Revenue and Market Share by Region (2019-2024) 4.2.2 Global Next Generation Antibody Therapeutics Revenue Forecast by Region (2025-2030) 5 Global Next Generation Antibody Therapeutics Market Size by Type and Application 5.1 Global Next Generation Antibody Therapeutics Market Size by Type 5.2 Global Next Generation Antibody Therapeutics Market Size by Application 6 North America 6.1 North America Next Generation Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America Next Generation Antibody Therapeutics Market Size by Type 6.4 North America Next Generation Antibody Therapeutics Market Size by Application 6.5 North America Next Generation Antibody Therapeutics Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe Next Generation Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe Next Generation Antibody Therapeutics Market Size by Type 7.4 Europe Next Generation Antibody Therapeutics Market Size by Application 7.5 Europe Next Generation Antibody Therapeutics Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China Next Generation Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China Next Generation Antibody Therapeutics Market Size by Type 8.4 China Next Generation Antibody Therapeutics Market Size by Application 9 APAC (excl. China) 9.1 APAC (excl. China) Next Generation Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) Next Generation Antibody Therapeutics Market Size by Type 9.4 APAC (excl. China) Next Generation Antibody Therapeutics Market Size by Application 9.5 APAC (excl. China) Next Generation Antibody Therapeutics Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America Next Generation Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America Next Generation Antibody Therapeutics Market Size by Type 10.4 Latin America Next Generation Antibody Therapeutics Market Size by Application 10.5 Latin America Next Generation Antibody Therapeutics Market Size by Country 10.5.1 Mecixo 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa Next Generation Antibody Therapeutics Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Type 11.4 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Application 11.5 Middle East & Africa Next Generation Antibody Therapeutics Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Market Competition by Manufacturers 12.1 Global Next Generation Antibody Therapeutics Market Revenue by Key Manufacturers (2020-2024) 12.2 Next Generation Antibody Therapeutics Competitive Landscape Analysis and Market Dynamic 12.2.1 Next Generation Antibody Therapeutics Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Roche 13.1.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Roche Next Generation Antibody Therapeutics Product Portfolio 13.1.3 Roche Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.2 Amgen 13.2.1 Amgen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Amgen Next Generation Antibody Therapeutics Product Portfolio 13.2.3 Amgen Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.3 Pfizer 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Pfizer Next Generation Antibody Therapeutics Product Portfolio 13.3.3 Pfizer Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.4 Takeda 13.4.1 Takeda Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Takeda Next Generation Antibody Therapeutics Product Portfolio 13.4.3 Takeda Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.5 Daiichi Sankyo 13.5.1 Daiichi Sankyo Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Daiichi Sankyo Next Generation Antibody Therapeutics Product Portfolio 13.5.3 Daiichi Sankyo Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.6 Seagen 13.6.1 Seagen Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Seagen Next Generation Antibody Therapeutics Product Portfolio 13.6.3 Seagen Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.7 Astellas 13.7.1 Astellas Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 Astellas Next Generation Antibody Therapeutics Product Portfolio 13.7.3 Astellas Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.8 GSK 13.8.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 GSK Next Generation Antibody Therapeutics Product Portfolio 13.8.3 GSK Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.9 Immunomedics 13.9.1 Immunomedics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Immunomedics Next Generation Antibody Therapeutics Product Portfolio 13.9.3 Immunomedics Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.10 Immunocore 13.10.1 Immunocore Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Immunocore Next Generation Antibody Therapeutics Product Portfolio 13.10.3 Immunocore Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 13.11 ADC Therapeutics 13.11.1 ADC Therapeutics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 ADC Therapeutics Next Generation Antibody Therapeutics Product Portfolio 13.11.3 ADC Therapeutics Next Generation Antibody Therapeutics Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 Next Generation Antibody Therapeutics Industry Chain Analysis 14.2 Next Generation Antibody Therapeutics Industry Raw Material and Suppliers Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 Next Generation Antibody Therapeutics Typical Downstream Customers 14.4 Next Generation Antibody Therapeutics Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support